Toll-Like Receptor-Based Strategies for Cancer Immunotherapy
Toll-like receptors (TLRs) are expressed and play multiple functional roles in a variety of immune cell types involved in tumor immunity. There are plenty of data on the pharmacological targeting of TLR signaling using agonist molecules that boost the antitumor immune response. A recent body of rese...
Saved in:
Main Authors: | Saghar Pahlavanneshan, Ali Sayadmanesh, Hamidreza Ebrahimiyan, Mohsen Basiri |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2021/9912188 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy
by: Ji-Yoon Noh, et al.
Published: (2020-01-01) -
Toll-Like Receptor 4 Activation in Cancer Progression and Therapy
by: Alja Oblak, et al.
Published: (2011-01-01) -
Targeting Toll-Like Receptors for Treatment of SLE
by: Christopher G. Horton, et al.
Published: (2010-01-01) -
Toll-Like Receptor Signaling and Liver Fibrosis
by: Tomonori Aoyama, et al.
Published: (2010-01-01) -
TIRAP, TRAM, and Toll-Like Receptors: The Untold Story
by: Valérie Lannoy, et al.
Published: (2023-01-01)